Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell cycle exit and neuronal differentiation protein 1 (CEND1), also known as BM88, is a neuronal lineage-specific transmembrane protein that plays a pivotal role in linking cell cycle exit with neuronal differentiation of neural precursor cells[1][3][5]. Expressed throughout the neuronal lineage from neural stem/progenitor cells to mature neurons, CEND1 orchestrates the timing of neuron-generating divisions, primarily promoting neuronal cell fate by downregulating proliferation-driving proteins (e.g., cyclin D1), upregulating cell cycle exit markers (e.g., p21), and suppressing Notch signaling[1][3][5]. Mechanistically, CEND1 acts through the p53-dependent Cyclin D1/pRb pathway and interacts with other regulatory proteins such as Ran-binding protein M (RanBPM) and kinase Dyrk1B to fine-tune the balance between proliferation and differentiation in developing neural tissue[2][3]. Loss-of-function models show deficits in neuronal differentiation, excess proliferation, and increased developmental apoptosis, underscoring its necessity for normal brain structure and function[3][5]. Although not a classical therapeutic target, its neurogenic and differentiation-promoting properties suggest possible utility in CNS repair or regeneration strategies[3][5].
Not applicable (no direct drugging known; acts via modulation of cell cycle and neural differentiation pathways)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell cycle exit and neuronal differentiation protein 1 (CEND1).